Daniel Laheru Selected Research

Daniel Laheru Research Topics

Disease

34	Neoplasms (Cancer) 10/2023 - 12/2005
34	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 12/2005
25	Adenocarcinoma 01/2023 - 12/2005
5	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 03/2003
5	Disease Progression 01/2019 - 04/2006
5	Neoplasm Metastasis (Metastasis) 01/2017 - 12/2010
3	Neutropenia 10/2013 - 09/2008
2	Tertiary Lymphoid Structures 10/2023 - 07/2014
2	Turcot syndrome 01/2020 - 01/2018
2	Microsatellite Instability 01/2020 - 01/2018
2	Fatigue 10/2013 - 12/2010
2	Ovarian Neoplasms (Ovarian Cancer) 12/2010 - 12/2008
1	Hepatocellular Carcinoma (Hepatoma) 10/2023
1	Pancreatitis 01/2022
1	Necrosis 01/2020
1	Mason-Type Diabetes 06/2019
1	Breast Neoplasms (Breast Cancer) 06/2019
1	Cardiomegaly (Heart Hypertrophy) 06/2019
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2018
1	Pathologic Complete Response 01/2018
1	Febrile Neutropenia 01/2016
1	Hypokalemia 01/2016
1	Colonic Neoplasms (Colon Cancer) 11/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2013
1	Thrombocytopenia (Thrombopenia) 08/2013
1	Cholangitis 08/2013

Drug/Important Bio-Agent (IBA)

12	Gemcitabine FDA Link 01/2023 - 04/2006
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 03/2003
5	Capecitabine (Xeloda)FDA Link 11/2022 - 12/2010
4	130-nm albumin-bound paclitaxelIBA 11/2022 - 10/2013
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2006
4	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 07/2009
3	AntibodiesIBA 01/2023 - 04/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 11/2014
3	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 03/2003
3	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2011
3	EnzymesIBA 01/2022 - 12/2010
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 11/2014
3	pembrolizumabIBA 01/2020 - 01/2018
3	VaccinesIBA 01/2020 - 11/2014
2	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2015
2	Leucovorin (Folinic Acid)FDA Link 01/2023 - 03/2003
2	Cell-Free Nucleic AcidsIBA 11/2022 - 05/2017
2	Drug CombinationsIBA 11/2022 - 03/2003
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021 - 01/2017
2	PlatinumIBA 04/2017 - 09/2015
2	Phosphotransferases (Kinase)IBA 01/2017 - 12/2012
2	Small Interfering RNA (siRNA)IBA 01/2017 - 04/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2013 - 03/2003
2	Carrier Proteins (Binding Protein)IBA 01/2012 - 04/2011
2	Genetic Markers (Genetic Marker)IBA 07/2009 - 03/2003
1	NivolumabIBA 01/2023
1	urelumabIBA 01/2023
1	GVAX vaccineIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 11/2022
1	palbociclibIBA 11/2022
1	A-Form DNA (A-DNA)IBA 11/2020
1	entrectinibIBA 01/2020
1	AntigensIBA 01/2020
1	larotrectinibIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	olaparibIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 06/2019
1	Epidermal Growth Factor (EGF)IBA 06/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2019
1	guadecitabineIBA 12/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	IodineIBA 01/2018
1	beta-lapachoneIBA 07/2017
1	NAD (NADH)IBA 07/2017
1	CatalaseIBA 07/2017
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 07/2017
1	Oxidoreductases (Dehydrogenase)IBA 07/2017
1	quinone (benzoquinone)IBA 07/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2017
1	Collagen Type I (Type I Collagen)IBA 01/2017
1	PND 1186IBA 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2016
1	ABT751IBA 01/2016
1	LigandsIBA 01/2015
1	InterferonsIBA 01/2015
1	CTLA-4 AntigenIBA 01/2015
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 08/2014
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 08/2014
1	Albumin-Bound Paclitaxel FDA Link 10/2013
1	Lipase (Acid Lipase)FDA Link 12/2012
1	CreatinineIBA 12/2012

Therapy/Procedure

30	Therapeutics 01/2023 - 03/2003
12	Drug Therapy (Chemotherapy) 01/2023 - 08/2008
6	Immunotherapy 10/2023 - 07/2014
4	Radiotherapy 01/2022 - 12/2010
3	Pancreaticoduodenectomy 09/2014 - 12/2005
2	Combination Drug Therapy (Combination Chemotherapy) 01/2023 - 02/2016
2	Adjuvant Chemotherapy 11/2020 - 01/2010
2	Neoadjuvant Therapy 01/2019 - 01/2018
1	Induction Chemotherapy 02/2016
1	capecitabine-irinotecan combination 01/2016
1	Aftercare (After-Treatment) 01/2015
1	Metastasectomy 11/2014